{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:48Z","timestamp":1786982688404,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-023-00821-7","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T05:02:14Z","timestamp":1695358934000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A case of emphysematous pyelonephritis in an older man with poorly controlled type 2 diabetes mellitus"],"prefix":"10.1007","volume":"13","author":[{"given":"Mayuka","family":"Nishikawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Kakegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8077-891X","authenticated-orcid":false,"given":"Yuji","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"821_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0002-9343(68)90245-3","volume":"44","author":"LI Schainuck","year":"1968","unstructured":"Schainuck LI, Fouty R, Cutler RE. Emphysematous pyelonephritis. A new case and review of previous observations. Am J Med. 1968;44:134\u20139.","journal-title":"Am J Med"},{"key":"821_CR2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.urology.2014.02.010","volume":"83","author":"D Olvera-Posada","year":"2014","unstructured":"Olvera-Posada D, Armengod-Fischer G, V\u00e1zquez-Lavista LG, Maldonado-\u00c1vila M, Rosas-Nava E, Manzanilla-Garc\u00eda H, et al. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology. 2014;83:1280\u20134.","journal-title":"Urology"},{"key":"821_CR3","volume":"78","author":"M Rahoui","year":"2022","unstructured":"Rahoui M, Ouanes Y, Chaker K, Bibi M, Dali KM, Sellami A, et al. Predictive factors for failure of conservative management in patients with emphysematous pyelonephritis. Ann Med Surg (Lond). 2022;78: 103930.","journal-title":"Ann Med Surg (Lond)"},{"issue":"11","key":"821_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jiac.2017.02.002","volume":"23","author":"Y Shingo","year":"2017","unstructured":"Japanese Association for Infectious Disease\/Japanese Society of Chemotherapy; JAID\/JSC Guide\/Guidelines to Clinical Management of Infectious Disease Preparing Committee; Urinary tract infection\/male genital infection working group, Shingo Y, Kiyohito I, Hiroshi H, Tadahiro N, Isao M, Tadashi H, et al. JAID\/JSC Guidelines for clinical management of infectious disease 2015 - urinary tract infection\/male genital infection. J Infect Chemother. 2017;23(11):733\u201351.","journal-title":"J Infect Chemother"},{"key":"821_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/archinte.160.6.797","volume":"160","author":"JJ Huang","year":"2000","unstructured":"Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160:797\u2013805.","journal-title":"Arch Intern Med"},{"key":"821_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S0022-5347(17)47635-X","volume":"134","author":"TE Ahlering","year":"1985","unstructured":"Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, et al. Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol. 1985;134:1086\u20138.","journal-title":"J Urol"},{"key":"821_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1148\/radiology.198.2.8596845","volume":"198","author":"YL Wan","year":"1996","unstructured":"Wan YL, Lee TY, Bullard MJ, Tsai CC. Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology. 1996;198:433\u20138.","journal-title":"Radiology"},{"key":"821_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1148\/radiology.171.3.2655002","volume":"171","author":"MC Soulen","year":"1989","unstructured":"Soulen MC, Fishman EK, Goldman SM, Gatewood OM. Bacterial renal infection: role of CT. Radiology. 1989;171:703\u20137.","journal-title":"Radiology"},{"key":"821_CR9","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1016\/j.jacr.2018.09.011","volume":"15","author":"P Nikolaidis","year":"2018","unstructured":"Expert Panel on Urologic Imaging, Nikolaidis P, Dogra VS, Goldfarb S, Gore JL, Harvin HJ, Heilbrun ME, et al. ACR appropriateness Criteria\u00ae acute pyelonephritis. J Am Coll Radiol. 2018;15:S232\u20139.","journal-title":"J Am Coll Radiol"},{"key":"821_CR10","unstructured":"Bonkat G, Bartoletti R, Bruy\u00e8re F, Cai T, Geerlings SE, K\u00f6ves B, et al. European Association of Urology 2022 guidelines on urological infections. https:\/\/uroweb.org\/guidelines\/urological-infections\/summary-of-changes\/2022. Accessed 5 Mar 2023."},{"key":"821_CR11","first-page":"373","volume":"67","author":"S Owa","year":"2021","unstructured":"Owa S, Sasaki K, Yonemura S, Sakurai M. A case of emphysematous pyelonephritis after starting treatment for acute pyelonephritis. Hinyokika Kiyo. 2021;67:373\u20139.","journal-title":"Hinyokika Kiyo"},{"key":"821_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3918\/jsicm.16.487","volume":"16","author":"T Takei","year":"2009","unstructured":"Takei T, Hama Y, Ito T, Takemoto M. Emphysematous pyelonephritis detected incidentally by a second CT examination after the improvement of septic shock. Nihon Shuchu Chiryo Igakukai Zasshi. 2009;16:487\u201391.","journal-title":"Nihon Shuchu Chiryo Igakukai Zasshi"},{"key":"821_CR13","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.juro.2008.01.019","volume":"179","author":"BK Somani","year":"2008","unstructured":"Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N\u2019Dow J. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol. 2008;179:1844\u20139.","journal-title":"J Urol"},{"key":"821_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.aju.2013.09.005","volume":"12","author":"OM Aboumarzouk","year":"2014","unstructured":"Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: time for a management plan with an evidence-based approach. Arab J Urol. 2014;12:106\u201315.","journal-title":"Arab J Urol"},{"key":"821_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/UA.UA_67_19","volume":"12","author":"RR Adapala","year":"2020","unstructured":"Adapala RR, Shetty R, Venugopal P, Prabhu GGL, Yalla D, Unnikrishnan B. Renal salvage, an achievable goal in patients with emphysematous pyelonephritis: outcomes of an algorithmic renal preserving strategy. Urol Ann. 2020;12:156\u201362.","journal-title":"Urol Ann"},{"key":"821_CR16","unstructured":"US Food and Drug Administration. FDA drug safety communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections; updated 2018. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious. Accessed 21 Oct 2022."},{"key":"821_CR17","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/dom.14082","volume":"22","author":"A Fisher","year":"2020","unstructured":"Fisher A, Fralick M, Filion KB, Dell\u2019Aniello S, Douros A, Tremblay E, et al. Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: a multi-site, prevalent new-user cohort study. Diabetes Obes Metab. 2020;22:1648\u201358.","journal-title":"Diabetes Obes Metab"},{"key":"821_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amjcard.2023.06.016","volume":"201","author":"P Tanvi","year":"2023","unstructured":"Tanvi P, Morgan C, Jesse H, Alamdeep K, Aliza L. Evaluating the safety of sodium-glucose cotransporter-2 inhibitors in a nationwide veterans health administration observational cohort study. Am J Cardiol. 2023;201:281\u20133.","journal-title":"Am J Cardiol"},{"key":"821_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7326\/M18-3136","volume":"171","author":"CV Dave","year":"2019","unstructured":"Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study. Ann Intern Med. 2019;171:248\u201356.","journal-title":"Ann Intern Med"},{"key":"821_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15193.Accessed26Jul","author":"R Mauro","year":"2023","unstructured":"Mauro R, Gian PF, Angelo A. Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023. https:\/\/doi.org\/10.1111\/dom.15193.Accessed26Jul.","journal-title":"Diabetes Obes Metab"},{"key":"821_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4140\/TCP.n.2023.276","volume":"38","author":"E Sarah","year":"2023","unstructured":"Sarah E, Christine L, Lindsay T. Evaluation of the safety and tolerability of sodium-glucose co-transporter 2 inhibitors in the older population: a systematic review. Sr Care Pharm. 2023;38:276\u201387.","journal-title":"Sr Care Pharm"},{"key":"821_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/0897190016679760","volume":"30","author":"WD Kufel","year":"2017","unstructured":"Kufel WD, Scrimenti A, Steele JM. A case of septic shock due to Serratia marcescens pyelonephritis and bacteremia in a patient receiving empagliflozin. J Pharm Pract. 2017;30:672\u20135.","journal-title":"J Pharm Pract"},{"key":"821_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s13730-021-00616-8","volume":"10","author":"A Woloshuk","year":"2021","unstructured":"Woloshuk A, Lee M, Assmus M, Agarwal D, Krambeck A, Large T. A case of ureteral fungal mass removal in a patient taking empagliflozin. CEN Case Rep. 2021;10:603\u20137.","journal-title":"CEN Case Rep"},{"key":"821_CR24","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553\u201379.","journal-title":"Diabetes Care"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-023-00821-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:04:53Z","timestamp":1717218293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-023-00821-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s13730-023-00821-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Declaration of Helsinki 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}